Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...
Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...
Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...
Mayo Electrophysiology laboratory ... first investing in the company in 2014. In 2022, Medtronic acquired Affera, the company behind its new catheter that ablates and maps the heart, for $925 ...